Application of methylene blue -vitamin C –N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial()

COVID-19 is a global catastrophic event that causes severe acute respiratory syndrome. The mechanism of the disease remains unclear, and hypoxia is one of the main complications. There is no currently approved protocol for treatment. The microbial threat as induced by COVID-19 causes the activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamdari, Daryoush Hamidi, Moghaddam, Ahmad Bagheri, Amini, Shahram, Keramati, Mohammad Reza, Zarmehri, Azam Moradi, Alamdari, Aida Hamidi, Damsaz, Mohammadamin, Banpour, Hamed, Yarahmadi, Amir, Koliakos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440159/
https://www.ncbi.nlm.nih.gov/pubmed/32828741
http://dx.doi.org/10.1016/j.ejphar.2020.173494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440159/
https://www.ncbi.nlm.nih.gov/pubmed/32828741
http://dx.doi.org/10.1016/j.ejphar.2020.173494

Ejemplares similares